• Respiratory Drugs, Ephedrine Sulphate
    Dosage form: Injection
    Strength: 50mg/10ml, 50mg/ml
    Indications/Special comments: Bronchospasm
    Dosage Administration: Bronchospasm- Children: IV Ephedrine sulfate: 0.75mg/kg or 25mg/m2 4 times daily or as otherwise determined by patient’s response. IM Ephedrine sulfate: 0.5mg/kg or 16.7mg/m² every 4 – 6 hours. SC Ephedrine sulfate: 0.5mg/kg or 16.7mg/m² every 4 – 6 hours; alternatively, 0.75mg/kg or 25mg/m² 4 times daily or as otherwise determined by patient’s response.
    View full drug info
  • Ophthalmic Anti-infectives, Erythromycin
    Dosage form: Eye Ointment
    Strength: 0.005
    Indications/Special comments: Topical prophylaxis of neonatal conjunctivitis caused by Chlamydia trachomatis. It is also used in the topical treatment of superficial ocular infections of the conjunctiva and/or cornea caused by susceptible organisms.
    Dosage Administration: Adult and Child: Ocular infection: Topical to the conjunctiva: a thin strip (approximately 1cm) of ointment up to six times a day, depending on the severity of the infection. Neonatal conjunctivitis/Ophthalmia neonatorum: Topical to each conjunctiva: a thin strip (approximately 0.5 to 1cm) of ointment as a single dose following caesarean or vaginal delivery.
    View full drug info
  • Ophthalmic Anti-infectives, Erythromycin
    Dosage form: Eye Drop
    Strength: 0.01
    Indications/Special comments: Topical prophylaxis of neonatal conjunctivitis caused by Chlamydia trachomatis. It is also used in the topical treatment of superficial ocular infections of the conjunctiva and/or cornea caused by susceptible organisms.
    Dosage Administration: Use in accordance with product leaflet
    View full drug info
  • Obstetric and Gynaecological Medications, Ergometrine Maleate
    Dosage form: Tablet
    Strength: 0.25mg, 0.5mg
    Indications/Special comments: Prevention and treatment of postpartum and postabortion haemorrhage in emergency situations and where oxytocin not available.
    Dosage Administration: Secondary postpartum haemorrhage: 0.2 - 0.4mg 2 - 4 times daily, usually for 48 hours.
    View full drug info
  • Obstetric and Gynaecological Medications, Ergometrine Maleate
    Dosage form: Injection
    Strength: 0.25mg/ml
    Indications/Special comments: Prevention and treatment of postpartum and postabortion haemorrhage in emergency situations and where oxytocin not available.
    Dosage Administration: Adult: Prevention and treatment of postpartum haemorrhage, when oxytocin is not available: IM injection: 200mcg when the anterior shoulder is delivered or immediately after birth. Excessive uterine bleeding: Slow IV injection: 250 - 500mcg when the anterior shoulder is delivered or immediately after birth.
    View full drug info
  • Insulin and Oral Antidiabetic, Exenatide
    Dosage form: Prefilled Pen Injection
    Strength: 250mcg/ml per 1.2ml; 250mcg/ml per 2.4ml
    Indications/Special comments: Management of type 2 diabetes as an adjunct to diet and exercise (not recommended as first-line therapy).
    Dosage Administration: SC: Adults: 5mcg within 60 min before morning and evening meal; after 1 month, dose may be increased to 10mcg depending on response.
    View full drug info
  • Insulin and Oral Antidiabetic, Exenatide
    Dosage form: Injection
    Strength: 2mg
    Indications/Special comments: Management of type 2 diabetes as an adjunct to diet and exercise (not recommended as first-line therapy).
    Dosage Administration: SC: Adults: 2mg every 7 days
    View full drug info
  • Hormonal Preparations, Ethinylestradiol + Gestodene
    Dosage form: Tablet
    Strength: 20 + 75mcg; 30 + 75mcg
    Indications/Special comments: Prevention of pregnancy. Regulation of menstrual cycle. Emergency contraception (some products). Treatment of heavy menstrual bleeding in women who choose to use intrauterine contraception as their method of contraception.Treatment of heavy menstrual bleeding in women who choose to use an oral contraceptive as their method of contraception.Treatment of premenstrual dysphoric disorder. Management of acne in women >14 yr who desire contraception, have no health problems, and have failed topical treatment. Increase folate levels in women who desire oral contraception to reduce the risk of neural tube defects in a pregnancy that occurs while taking or shortly after discontinuing the product.
    Dosage Administration: Adults: On 21-day regimen, take first tablet on first Sunday after menses begins (take on Sunday if menses begins on Sunday) for 21 days, then skip 7 days and begin again. Regimen may also be started on first day of menses, continue for 21 days, then skip 7 days and begin again. Some regimens contain 7 placebo tablets, so that 1 tablet is taken every day for 28 days
    View full drug info
  • Gastrointestinal System Agents, Esomeprazole
    Dosage form: Injection
    Strength: 40mg
    Indications/Special comments: GERD with erosive esophagitis, duodenal ulcer prophylaxis, gastric ulcer prophylaxis.
    Dosage Administration: Adult: GERD with Erosive Esophagitis: 20mg or 40mg IV injection once a day, over no less than 3 minutes; or IV infusion once a day, over no less than 10 to 30 minutes. Duodenal Ulcer Prophylaxis: -Initial dose: 80mg IV infusion over 30 minutes; Maintenance dose: 8mg/hr IV continuous infusion for a total of 72 hours (includes initial 30 minute dose plus 71.5 hours of continuous infusion). Gastric Ulcer Prophylaxis: Initial dose: 80mg IV infusion over 30 minutes; Maintenance dose: 8mg/hr IV continuous infusion for a total of 72 hours (includes initial 30 minute dose plus 71.5 hours of continuous infusion). Child: GERD with Erosive Esophagitis: Less than 1 month: Not recommended.1 month to less than 1 year: 0.5mg/kg IV infused over 10 to 30 minutes; 1 to 17 years: Less than 55 kg: 10mg IV infused over 10 to 30 minutes; 55 kg or more: 20mg IV infused over 10 to 30 minutes. Erosive Esophagitis:Healing: Less than 1 year: Data not available. 1 to 11 years: Less than 20 kg: 10mg once a day for 8 weeks; 20 kg or more: 10mg or 20mg once a day for 8 weeks; 12 to 17 years: 20 or 40mg once a day for 4 to 8 weeks; Comment: Doses over 1 mg/kg/day have not been studied. Erosive Esophagitis due to acid-mediated GERD: Less than 1 month: Data not available; 1 month to less than 1 year old: 3 kg to 5 kg: 2.5mg once a day; Greater than 5 kg to 7.5 kg: 5mg once a day; Greater than 7.5 kg to 12 kg: 10mg once a day; Duration of therapy: For up to 6 weeks. Comment: Doses over 1.33mg/kg/day have not been studied. 1 year and older: Data not available. Uses: Short-term treatment in the healing and symptomatic resolution of diagnostically confirmed erosive oesophagitis; short term treatment of erosive esophagitis due to acid-mediated GERD in infants.
    View full drug info
  • Cardiovascular Drugs, Ezetimibe + Simvastatin
    Dosage form: Tablet
    Strength: 10mg + 20mg; 10mg + 40mg
    Indications/Special comments: Homozygous familial hypercholesterolemia; Primary hyperlipidemia; Simvastatin: Primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) according to the American College of Cardiology/American Heart Association.
    Dosage Administration: Homozygous familial hypercholesterolemia: Adults: Ezetimibe 10 mg and simvastatin 40 mg once daily in the evening. Heterozygous familial hypercholesterolemia (HeFH): Initial: Ezetimibe 10mg and simvastatin 10 to 20mg once daily in the evening. Dosing range: Ezetimibe 10mg and simvastatin 10 to 40mg once daily; maximum dose: Ezetimibe 10mg and simvastatin 40mg once daily.
    View full drug info